Maternal caffeine consumption and risk of congenital limb deficiencies

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 94, Issue 12, 2012, Pages 1033-1043

  Chen, Lei ^a   Bell, Erin M ^b   Browne, Marilyn L ^b,c   Druschel, Charlotte M ^b,c   Romitti, Paul A ^d   Schmidt, Rebecca J ^e   Burns, Trudy L ^d   Moslehi, Roxana ^b   Olney, Richard S ^f  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY AT ALBANY   (United States)

^c NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Caffeine; Coffee; Congenital limb deficiencies; Soda; Tea

Indexed keywords

CAFFEINE; SODIUM CARBONATE;

ADULT; ARTICLE; BEVERAGE; CACAO; CASE CONTROL STUDY; COFFEE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; INFANT; LIMB DEFECT; MAJOR CLINICAL STUDY; MALE; MATERNAL NUTRITION; MATERNAL SMOKING; PREGNANCY; PRIORITY JOURNAL; TEA;

ADOLESCENT; ADULT; BEVERAGES; CACAO; CAFFEINE; CASE-CONTROL STUDIES; CHILD; COFFEE; FEMALE; HUMANS; LIMB DEFORMITIES, CONGENITAL; MALE; RISK ASSESSMENT; TEA; YOUNG ADULT;

ANIMALIA;

EID: 84871171642     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23050     Document Type: Article

References (76)

1. 2000. State birth defects surveillance programs directory. Teratology 61: 33-85.
2. 2007. State birth defects surveillance program directory. Birth Defects Res A Clin Mol Teratol 79: 815-873.
3. Aberg A, Westbom L, Källén B. 2001. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 61: 85-95.
4. Adams MM, Mulinare J, Dooley K. 1989. Risk factors for conotruncal cardiac defects in Atlanta. J Am Coll Cardiol 14: 432-442.
5. Akaike H. 1974. A new look at the statistical model identification. IEEE Trans Automat Contr 19: 716-723.
6. Aro T, Heinonen OP, Saxén L. 1982. Incidence and secular trends of congenital limb defects in Finland. Int J Epidemiol 11: 239-244.
7. Bayley TM, Dye L, Jones S, et al. 2002. Food cravings and aversions during pregnancy: relationships with nausea and vomiting. Appetite 38: 45-51.
8. Beck SL, Urbano CM. 1991. Potentiating effect of caffeine on the teratogenicity of acetazolamide in C57BL/6J mice. Teratology 44: 241-250.
9. Bracken MB, Triche E, Grosso L, et al. 2002. Heterogeneity in assessing self-reports of caffeine exposure: implications for studies of health effects. Epidemiology 13: 165-171.
10. Brent RL, Christian MS, Diener RM. 2011. Evaluation of the reproductive and developmental risks of caffeine. Birth Defects Res B Dev Reprod Toxicol 92: 152-187.
11. Browne ML. 2006. Maternal exposure to caffeine and risk of congenital anomalies: a systematic review. Epidemiology 17: 324-331.
12. Browne ML, Bell EM, Druschel CM, et al. 2007. Maternal caffeine consumption and risk of cardiovascular malformations. Birth Defects Res A Clin Mol Teratol 79: 533-543.
13. Browne ML, Hoyt AT, Feldkamp ML, et al. 2011. Maternal caffeine intake and risk of selected birth defects in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 91: 93-101.
14. Charles BG, Townsend SR, Steer PA, et al. 2008. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring. Ther Drug Monit 30: 709-716.
15. Cogswell ME, Bitsko RH, Anderka M, et al. 2009. Control selection and participation in an ongoing, population-based, case-control study of birth defects: the National Birth Defects Prevention Study. Am J Epidemiol 170: 975-985.
16. Collier SA, Browne ML, Rasmussen SA, et al. 2009. Maternal caffeine intake during pregnancy and orofacial clefts. Birth Defects Res A Clin Mol Teratol 85: 842-849.
17. Fedrick J. 1974. Anencephalus and maternal tea drinking: evidence for a possible association. Proc R Soc Med 67: 356-360.
18. Ferencz C, Rubin JD, Loffredo C, Magee CA. 1993. Epidemiology of congenital heart disease: the Baltimore-Washington Infant Study, 1981-1989. Mt. Kisco, NY: Futura Publishing.
19. Fixler DE, Threlkeld N. 1998. Prenatal exposures and congenital heart defects in Down syndrome infants. Teratology 58: 6-12.
20. Frary CD, Johnson RK, Wang MQ. 2005. Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 105: 110-113.
21. Fujii T, Nakatsuka T. 1983. Potentiating effects of caffeine on teratogenicity of alkylating agents in mice. Teratology 28: 29-33.
22. Fujii T, Sasaki H, Nishimura H. 1969. Teratogenicity of caffeine in mice related to its mode of administration. Jpn J Pharmacol 19: 134-138.
23. Furuhashi N, Sato S, Suzuki M, et al. 1985. Effects of caffeine ingestion during pregnancy. Gynecol Obstet Invest 19: 187-191.
24. Greenland S, Rothman KJ. 2008. Fundamentals of epidemiologic data analysis. In: Rothman KJ, Greenland S, Lash TL, editors. Modern Epidemiology. Philadelphia, PA: Lippincott Williams & Wilkins. pp. 213-217.
25. Holmes LB. 2002. Teratogen-induced limb defects. Am J Med Genet 112: 297-303.
26. Holmes LB. 2011. Limb malformations. Common Malformations. New York, NY: Oxford University Press. pp. 146-205.
27. Hosmer DW, Lemeshow S. 2000. Chapter 5: Assessing the fit of the model applied logistic regression. 2 ed. New York, NY: Wiley.
28. Knight CA, Knight I, Mitchell DC, Zepp JE. 2004. Beverage caffeine intake in US consumers and subpopulations of interest: estimates from the Share of Intake Panel survey. Food Chem Toxicol 42: 1923-1930.
29. Knol MJ, VanderWeele TJ, Groenwold RH, et al. 2011. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol 26: 433-438.
30. Knutti R, Rothweiler H, Schlatter C. 1982. The effect of pregnancy on the pharmacokinetics of caffeine. Arch Toxicol Suppl 5: 187-192.
31. Kurppa K, Holmberg PC, Kuosma E, Saxén L. 1983. Coffee consumption during pregnancy and selected congenital malformations: a nationwide case-control study. Am J Public Health 73: 1397-1399.
32. Lawson CC, LeMasters GK, Levin LS, Liu JH. 2002. Pregnancy hormone metabolite patterns, pregnancy symptoms, and coffee consumption. Am J Epidemiol 156: 428-437.
33. Linn S, Schoenbaum SC, Monson RR, et al. 1982. No association between coffee consumption and adverse outcomes of pregnancy. N Engl J Med 306: 141-145.
34. Manderson JG, Mullan B, Patterson CC, et al. 2002. Cardiovascular and metabolic abnormalities in the offspring of diabetic pregnancy. Diabetologia 45: 991-996.
35. March of Dimes. 2011. Caffeine in pregnancy. Available at: http://www.marchofdimes.com/pregnancy/nutrition_caffeine.html. Accessed May 22, 2012.
36. Marks V, Kelly JF. 1973. Absorption of caffeine from tea, coffee, and coca cola. Lancet 1: 827.
37. McDonald AD, Armstrong BG, Sloan M. 1992. Cigarette, alcohol, and coffee consumption and congenital defects. Am J Public Health 82: 91-93.
38. Miller EA, Manning SE, Rasmussen SA, et al. 2009. Maternal exposure to tobacco smoke, alcohol and caffeine, and risk of anorectal atresia: National Birth Defects Prevention Study 1997-2003. Paediatr Perinat Epidemiol 23: 9-17.
39. Miller KE. 2008. Energy drinks, race, and problem behaviors among college students. J Adolesc Health 43: 490-497.
40. Mills JL, McPartlin JM, Kirke PN, et al. 1995. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345: 149-151.
41. Mongraw-Chaffin ML, Cohn BA, Cohen RD, Christianson RE. 2008. Maternal smoking, alcohol consumption, and caffeine consumption during pregnancy in relation to a son's risk of persistent cryptorchidism: a prospective study in the Child Health and Development Studies cohort, 1959-1967. Am J Epidemiol 167: 257-261.
42. Moriguchi M, Scott WJJr. 1986. Prevention of caffeine-induced limb malformations by maternal adrenalectomy. Teratology 33: 319-322.
43. Natsume N, Kawai T, Ogi N, Yoshida W. 2000. Maternal risk factors in cleft lip and palate: case control study. Br J Oral Maxillofac Surg 38: 23-25.
44. National Confectioners Association (NCA). 2009. Fun facts about chocolate. Available at: http://nca.files.cms-plus.com/Trends_Forecast_Ex_ Summary.pdf. Accessed May 22, 2012.
45. Nehlig A, Debry G. 1994. Potential teratogenic and neurodevelopmental consequences of coffee and caffeine exposure: a review on human and animal data. Neurotoxicol Teratol 16: 531-543.
46. Nelson MM, Forfar JO. 1971. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J 1: 523-527.
47. Nishimura H, Nakai K. 1960. Congenital malformations in offspring of mice treated with caffeine. Proc Soc Exp Biol Med 104: 140-142.
48. Olsen J, Overvad K, Frische G. 1991. Coffee consumption, birthweight, and reproductive failures. Epidemiology 2: 370-374.
49. Parsons WD, Neims AH. 1978. Effect of smoking on caffeine clearance. Clin Pharmacol Ther 24: 40-45.
50. Patwardhan RV, Desmond PV, Johnson RF, Schenker S. 1980. Impaired elimination of caffeine by oral contraceptive steroids. J Lab Clin Med 95: 603-608.
51. Rasmussen SA, Olney RS, Holmes LB, et al. 2003. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 67: 193-201.
52. Reissig CJ, Strain EC, Griffiths RR. 2009. Caffeinated energy drinks-a growing problem. Drug Alcohol Depend 99: 1-10.
53. Ritter EJ, Scott WJ, Wilson JG, et al. 1982. Potentiative interactions between caffeine and various teratogenic agents. Teratology 25: 95-100.
54. Rosenberg L, Mitchell AA, Shapiro S, Slone D. 1982. Selected birth defects in relation to caffeine-containing beverages. JAMA 247: 1429-1432.
55. Rothman KJ, Greenland S, Lash T. 2008. Modern Epidemiology. 3 ed. Philadelphia, PA: Lippincott Williams & Wilkins.
56. Sadler TW. 2009. Langman's Medical Embryology. 11 ed: Lippincott Williams & Wilkins. pp. 125-142.
57. Samrén EB, van Duijn CM, Christiaens GC, et al. 1999. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 46: 739-746.
58. Schmidt RJ. 2007. Maternal caffeine intake, select metabolic gene variants, and neural tube defects (NTDS) [Doctoral Dissertation]. Iowa City, IA: University of Iowa.
59. Schmidt RJ, Romitti PA, Burns TL, et al. 2009. Maternal caffeine consumption and risk of neural tube defects. Birth Defects Res A Clin Mol Teratol 85: 879-889.
60. Scott WJJr. 1983. Caffeine-induced limb malformations: description of malformations and quantitation of placental transfer. Teratology 28: 427-435.
61. Selevan SG, Lemasters GK. 1987. The dose-response fallacy in human reproductive studies of toxic exposures. J Occup Med 29: 451-454.
62. Slickers JE, Olshan AF, Siega-Riz AM, et al. 2008. Maternal body mass index and lifestyle exposures and the risk of bilateral renal agenesis or hypoplasia: the National Birth Defects Prevention Study. Am J Epidemiol 168: 1259-1267.
63. Tikkanen J, Heinonen OP. 1990. Risk factors for cardiovascular malformations in Finland. Eur J Epidemiol 6: 348-356.
64. Tikkanen J, Heinonen OP. 1991. Maternal exposure to chemical and physical factors during pregnancy and cardiovascular malformations in the offspring. Teratology 43: 591-600.
65. Tikkanen J, Heinonen OP. 1992a. Risk factors for atrial septal defect. Eur J Epidemiol 8: 509-515.
66. Tikkanen J, Heinonen OP. 1992b. Risk factors for conal malformations of the heart. Eur J Epidemiol 8: 48-57.
67. Tikkanen J, Heinonen OP. 1994. Risk factors for hypoplastic left heart syndrome. Teratology 50: 112-117.
68. Torfs CP, Christianson RE. 1999. Maternal risk factors and major associated defects in infants with Down syndrome. Epidemiology 10: 264-270.
69. Torfs CP, Christianson RE. 2000. Effect of maternal smoking and coffee consumption on the risk of having a recognized Down syndrome pregnancy. Am J Epidemiol 152: 1185-1191.
70. Van Allen MI. 1981. Fetal vascular disruptions: mechanisms and some resulting birth defects. Pediatr Ann 10: 219-233.
71. Vistisen K, Poulsen HE, Loft S. 1992. Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis 13: 1561-1568.
72. Weathersbee PS, Lodge JR. 1977. Caffeine: its direct and indirect influence on reproduction. J Reprod Med 19: 55-63.
73. Wenstrom KD, Johanning GL, Johnston KE, DuBard M. 2001. Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol 184: 806-812, discussion812-807.
74. Werler MM, Mitchell AA, Shapiro S. 1992. Demographic, reproductive, medical, and environmental factors in relation to gastroschisis. Teratology 45: 353-360.
75. Wilson TT. 2004. Caffeine and Health. Beverages in Nutrition and Health. Totowa, NJ: Humana Press. p 173.
76. Yoon PW, Rasmussen SA, Lynberg MC, et al. 2001. The National Birth Defects Prevention Study. Public Health Rep 116 Suppl 1: 32-40.